JACOBS LEVY EQUITY MANAGEMENT, INC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 85 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$1,625,000
-53.9%
541,520
-28.7%
0.01%
-54.2%
Q2 2021$3,526,000
+2.1%
759,918
+32.1%
0.02%
-11.1%
Q1 2021$3,453,000
+66.8%
575,443
+45.7%
0.03%
+50.0%
Q4 2020$2,070,000
+421.4%
394,957
+243.8%
0.02%
+350.0%
Q3 2020$397,000
-81.7%
114,878
-54.1%
0.00%
-83.3%
Q2 2020$2,172,000
+18.9%
250,251
-20.6%
0.02%
+4.3%
Q1 2020$1,827,000
-24.9%
315,047
-6.7%
0.02%
-4.2%
Q4 2019$2,433,000
+768.9%
337,496
+878.2%
0.02%
+500.0%
Q1 2019$280,00034,5000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,117,00023.05%
Invus Financial Advisors, LLC 2,189,998$12,702,0006.24%
Leap Investments LP 13,400$78,0000.11%
Moloney Securities Asset Management, LLC 51,950$301,0000.11%
Verity Asset Management, Inc. 14,748$86,0000.11%
Virtus ETF Advisers LLC 43,010$249,0000.10%
Investors Financial Group, LLC 15,850$92,0000.09%
SUNFLOWER BANK, NA WEALTH MANAGEMENT 20,000$116,0000.04%
Baillie Gifford 3,803,014$22,057,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 315,047$1,827,0000.02%
View complete list of UNITY BIOTECHNOLOGY INC shareholders